Doximity (NYSE:DOCS) Stock Rating Upgraded by The Goldman Sachs Group

Doximity (NYSE:DOCS) was upgraded by research analysts at The Goldman Sachs Group from a “strong sell” rating to a “hold” rating in a research note issued to investors on Friday,Zacks.com reports.

Other research analysts have also recently issued research reports about the stock. Wall Street Zen cut shares of Doximity from a “buy” rating to a “hold” rating in a report on Saturday. Weiss Ratings restated a “hold (c+)” rating on shares of Doximity in a research report on Wednesday, December 24th. Finally, Barclays upgraded Doximity to a “strong-buy” rating in a report on Monday, December 8th. Two equities research analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, Doximity has an average rating of “Buy”.

Doximity Price Performance

Doximity stock opened at $43.85 on Friday. The stock has a market cap of $8.26 billion, a PE ratio of 34.80, a P/E/G ratio of 2.03 and a beta of 1.39. Doximity has a 1 year low of $43.21 and a 1 year high of $85.21.

Doximity Company Profile

Doximity, trading as DOCS, operates a digital professional network and communications platform designed primarily for clinicians. Headquartered in San Francisco, the company connects physicians, nurse practitioners, physician assistants and other healthcare professionals, providing tools that streamline clinical communication, telehealth delivery and access to specialty-specific medical information. Its platform is positioned as a professional hub where clinicians manage their workflows, stay current with medical news and collaborate securely with peers.

The company’s offerings include secure messaging and video telehealth capabilities that enable clinicians to consult with patients and colleagues while protecting patient information.